natgillin/translations-raw huggingface dataset:
Regular intake of IOA is then resumed after the yellow placebo tablets have been taken of the second pack. 
Po končanem jemanju rumenih placebo tablet iz drugega pretisnega omota naj ženska nadaljuje z običajnim jemanjem zdravila IOA.
Latvija 
Italia
Lietuva 
Hrvatska
• if you have ever had a heart attack or a stroke; 
• če imate hudo drisko;
Tabulated summary of adverse reactions 
Povzetek varnostnega profila
Should any of the conditions appear for the first time during IOA use, the medicinal product should be stopped 
Če se katera od naštetih bolezni ali motenj prvič pojavi prav med jemanjem zdravila IOA, mora ženska nemudoma prenehati z uporabo tega zdravila: • Prisotna venska trombembolija (VTE) ali tveganje zanjo.
This might happen: 
To se lahko zgodi, e:
This soon disappears. 
To kmalu mine.
ATC code: A10A B01. 
Oznaka ATC: A10A B01.
They must not give you any food or drink as it could choke you. 
Ne smejo vam dajati hrane ali pija e, ker vas lahko zaduši.
• if signs of allergy spread to other parts of the body, or 
• se znaki alergije razširijo na druge dele telesa ali
This means that it will start to lower your blood sugar about half an hour after you take it. 
To pomeni, da za ne krvni sladkor zniževati približno pol ure potem, ko ga uporabite.
Signs of allergy. 
Znaki alergije.
Date of latest renewal: 18 September 2007 
Datum podaljšanja dovoljenja za promet: 18. september 2007
The physician must therefore take possible interactions into account and should always ask his patients about any medicinal products they take. 
Zdravnik mora zato upoštevati možna medsebojna delovanja in mora bolnike vedno povprašati po vseh zdravilih, ki jih uporabljajo.
Insulin preparations which have been frozen must not be used. 
Pripravkov insulina, ki so bili zamrznjeni, se ne sme uporabiti.
This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery). 
To je lahko nevarno v okoliš inah, v katerih sta ti zmožnosti posebej pomembni (npr. pri vožnji avta ali upravljanju s stroji).
These may be signs of a very serious condition called diabetic ketoacidosis. 
To so lahko znaki zelo resnega stanja, ki ga imenujemo diabeti na ketoacidoza.
For incompatibilities see section 6.2. 
Za inkompatibilnosti glejte poglavje 6.2.
If you do not respond to glucagon treatment, you will have to be treated in a hospital. 
e se ne odzovete na zdravljenje z glukagonom, bo potrebno zdravljenje v bolnišnici.
You may have a very rare serious allergic reaction to Velosulin or one of its ingredients (called a systemic allergic reaction). 
Morda imate zelo redko, resno alergijsko reakcijo na Velosulin ali eno njegovih sestavin (to imenujemo sistemska alergijska reakcija).
Usually, the first symptoms of hyperglycaemia set in gradually, over a period of hours or days. 
Prvi simptomi hiperglikemije se ponavadi razvijejo postopoma, v nekaj urah ali dneh.
Trials have indicated a t½ of about 2-5 hours. 
Preskušanja so pokazala t1/2 približno 2-5 urah.
Vision problems. 
Težave z vidom.
• Repeatedly taking less insulin than you need 
• Ve krat zapored ste uporabili manj insulina, kot ga potrebujete.
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND 
• POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN U INKOVITO UPORABO
Most reactions are transitory and disappear during continued treatment. 
Ve ina teh reakcij je prehodnih in med nadaljevanjem zdravljenja izginejo.
Do not store them in or too near the freezer section or cooling element. 
Ne shranjujte v zamrzovalniku in ne preblizu zamrzovalnika ali hladilnega elementa.
The data are limited but suggest that the pharmacokinetic profile in children and adolescents may be similar to that in adults. 
Podatkov je malo, vendar nakazujejo, da utegne biti farmakokineti ni profil pri otrocih in mladostnikih podoben kot pri odraslih.
Seek medical advice immediately: 
Potem takoj poiš ite zdravniški nasvet.
If an adjustment is needed when switching the patients to Velosulin, it may occur with the first dose or during the first several weeks or months. 
e je po prehodu bolnikov na Velosulin potrebna prilagoditev, utegne biti potrebna že pri prvem odmerku ali v prvih nekaj tednih ali mesecih.
Chrildren and adolescents 
Otroci in mladostniki
If it does not disappear, see your doctor. 
e ne izgine, pojdite k zdravniku.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first suthorisation: 07 October 2002 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 7. oktober 2002
Velosulin contains metacresol, which may cause allergic reactions. 
Velosulin vsebuje metakrezol, ki lahko povzro i alergijske reakcije.
Treatment of diabetes mellitus. 
Zdravljenje diabetesa mellitusa.
The individual insulin requirement is usually between 0.3 and 1.0 IU/kg/day. 
Individualna potreba po insulinu je ponavadi od 0,3 do 1,0 i. e./kg/dan.
Tell your relatives, friends and close colleagues that if you pass out (become unconscious), they must: turn you on your side and seek medical advice straight away. 
Svojim sorodnikom, prijateljem in bližnjim sodelavcem povejte, da vas morajo v primeru, da se onesvestite (izgubite zavest), položiti na bok in nemudoma poiskati zdravniško pomo .
Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes. 
Glukozo, dano intravensko, je treba uporabiti tudi v primeru, e se bolnik v 10 do 15 minutah ne odzove na glukagon.
Usually, 40-60% of the total daily dose is given as a continuous basal rate and the remaining 40-60% as boluses divided between the three main meals. 
Ponavadi se od 40 do 60 % celotnega dnevnega odmerka daje kot stalna bazalna infuzija, preostalih 40 do 60 % pa v bolusih, razdeljenih med tri glavne obroke.
The vials that are being used or about to be used is not to be kept in a refrigerator. 
Viale, ki jih uporabljate ali jih boste pravkar uporabili, ne shranjujte v hladilniku.
Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. 
Prilagoditev odmerjanja utegne biti potrebna tudi v primeru, e bolniki spremenijo svojo telesno dejavnost ali obi ajno prehrano.
Insulin in the blood stream has a half-life of a few minutes. 
Insulin v krvnem obtoku ima razpolovni as nekaj minut.
However, hypoglycaemia may develop over sequential stages: 
Vendar se hipoglikemija lahko razvije v dveh zaporednih stopnjah:
However, the Velosulin dosage may need to be adjusted. 
Lahko pa je potrebna prilagoditev odmerjanja zdravila Velosulin.
The pharmacokinetics of insulin products are therefore affected by significant intra- and inter-individual variation. 
Na farmakokinetiko insulinskih zdravil torej vplivajo pomembne intra- in interindividualne razlike.
Inject the insulin straight away under the skin. 
Insulin takoj injicirajte pod kožo.
The maximum plasma concentration is reached within 1.5-2.5 hours after subcutaneous administration. 
Absorpcija Najve ja koncentracija v plazmi je dosežena v 1,5 do 2,5 urah po subkutani uporabi.
During use: do not refrigerate. 
Med uporabo: ne shranjujte v hladilniku.
Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites. 
Subkutano injiciranje v trebušno steno zagotavlja hitrejšo absorpcijo kot na drugih mestih injiciranja.
Many medicines affect the way glucose works in your body and they may influence your insulin dose. 
Številna zdravila vplivajo na delovanje glukoze v telesu in lahko tako vplivajo na vaš odmerek insulina.
EXP/ During use: use within 6 weeks 
Med uporabo: porabite v 6 tednih.
If you are given glucagon you will need glucose or a sugary snack as soon as you are conscious. 
e dobite glukagon, boste potrebovali glukozo ali sladek prigrizek, takoj ko se zaveste.
Causes of a hypo 
Vzroki za hipe
WHAT TO DO IN AN EMERGENCY 
Ukrepanje v nujnih primerih.
This is called acute painful neuropathy and it usually disappears. 
Pojav imenujemo akutna bole a nevropatija in ponavadi izgine.
Do not use Velosulin after the expiry date which is stated on the label and the carton. 
Zdravila Velosulin ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki in škatlici.
A number of cleavage (hydrolysis) sites on the human insulin molecule have been proposed; none of the metabolites formed following the cleavage are active. 
Predlagali so številna mesta razcepa (hidrolize) na molekuli humanega insulina; nobeden od presnovkov, nastalih po razcepu, ni aktiven.
Insulin injection: 
Injiciranje insulina:
The patient should read and follow the instructions that accompany the infusion pump and use the correct reservoir and catheter for the pump (see section 6.6). 
Bolnik mora prebrati in upoštevati navodila, priložena infuzijski rpalki, in uporabljati pravi rezervoar in kateter za rpalko (glejte poglavje 6.6).
Keep the vials in the original package. 
Viale hranite v originalni ovojnini!
• If you eat too little or miss a meal 
• premalo jeste ali izpustite obrok,
Insulin requirements usually fall in the first trimester and subsequently increase during the second and third trimesters. 
Potreba po insulinu se v prvem trimese ju ponavadi zmanjša, potem pa se v drugem in tretjem trimese ju zve a.
Transferring a patient to another type or brand of insulin should be done under strict medical supervision. 
Prehod na novo vrsto ali znamko insulina mora potekati pod strogim zdravniškim nadzorom.
Changes in strength, brand (manufacturer), type (fast-, dual-, long-acting insulin etc.), origin (animal, human or analogue insulin) and/or method of manufacture (recombinant DNA versus animal source insulin) may result in a need for a change in dosage. 
Spremembe jakosti, znamke (izdelovalec), vrste (hitro-, dvojno-, dolgodelujo i insulin itn.), izvora (živalski, humani ali analogni insulin) in/ali na ina izdelave (rekombinantna DNA ali živalski vir insulina) lahko zahtevajo spremembe v odmerjanju.
• Having forgotten to take your insulin 
• Pozabili ste si dati insulin.
Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement (see sections 4.8 and 4.9). 
Hipoglikemija se lahko pojavi, e je odmerek insulina prevelik glede na potrebo po insulinu (glejte poglavji 4.8 in 4.9).
Infections can be minimised by careful attention to personal hygiene of the hands and infusion site and by frequent changes of catheter (maximum usage 2 days). 
Okužbe je treba minimizirati tako, da se nameni posebno pozornost osebni higieni rok in infuzijskega mesta, in s pogostimi menjavami katetra (najve 2-dnevna uporaba).
The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected. 
Igla mora ostati pod kožo vsaj 6 sekund, da je zanesljivo vbrizgan celotni odmerek.
30 months when stored between 2°C - 8°C. 
30 mesecev pri temperaturi od 2 °C do 8 °C.
Changing the site with each injection may help to prevent such skin changes. 
Menjavanje injekcijskega mesta pri vsaki injekciji pomaga prepre iti takšne kožne spremembe.
Dosage adjustment 
Prilagoditev odmerjanja
A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 - 6.1 mmol/l) induced by intravenous treatment with another fast acting human insulin (Actrapid) reduced mortality by 42% (8% versus 4.6%). 
Klini no preskušanje zdravljenja hiperglikemije (glukoza v krvi nad 10 mmol/l) v eni sami intenzivni enoti pri 204 diabeti nih in 1344 nediabeti nih bolnikih po ve ji operaciji je pokazala, da je normoglikemija (glukoza v krvi 4,4-6,1 mmol/l), dosežena z intravenskim zdravljenjem z drugim hitrodelujo im humanim insulinom (Actrapid), zmanjšala umrljivost za 42 % (8 % v primerjavi s
The pharmacokinetic profile has been studied in a small number (n=18) of diabetic children (aged 612 years) and adolescents (aged 13-17 years) using another fast-acting human insulin, (Actrapid). 
Farmakokineti ni profil zdravila Velosulin je bil raziskan pri majhnem številu (n = 18) diabeti nih otrok (starost 6-12 let) in mladostnikov (starost 13-17 let)., ki so uporabljali drug hitro delujo insulin (Actrapid).
• Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional. 
• Hude hipoglikemije, ko je bolnik nezavesten, je mogo e zdraviti z glukagonom (0,5 do 1 mg), ki ga da ustrezno podu ena oseba intramuskularno ali subkutano ali z glukozo, ki jo da zdravstveni delavec intravensko.
Use only catheters where the material in contact with the insulin is made of polyethylene or polypropylene. 
Uporabljajte le katetre, v katerih je material, ki je v stiku z insulinom, iz polietilena ali polipropilena.
Very rare - Diabetic retinopathy 
Zelo redki - diabeti na retinopatija
Velosulin is accompanied by a package leaflet with detailed instruction for use to be followed. 
Zdravilu Velosulin je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
Patients should be advised to take precautions to avoid hypoglycaemia whilst driving. 
Bolnikom je treba svetovati, naj upoštevajo ustrezne previdnostne ukrepe, da bi se izognili hipoglikemiji med upravljanjem vozila.
Inadequate dosage or discontinuation of treatment, especially in type 1 diabetes, may lead to hyperglycaemia. 
Neustrezno odmerjanje ali prekinitev zdravljenja lahko, zlasti pri diabetesu tipa 1, povzro i hiperglikemijo.
Continuous subcutaneous infusion eliminates some of the variations/fluctuations inherent to injection therapy. 
Stalno subkutano infundiranje odpravi nekatere spremembe/nihanja, povezane z injekcijskim zdravljenjem.
This is part of a multipack and not for sale of individual vials 
To je del pakiranja z ve vialami in ni namenjen za prodajo posameznih vial.
If your doctor has switched you from one type or brand of insulin to another, your dose may have to be adjusted by your doctor. 
e vam zdravnik eno vrsto ali znamko insulina zamenja z drugo, vam bo morda moral prilagoditi odmerek.
If you don't treat it, this could lead to diabetic coma and death. 
e ga ne zdravite, lahko povzro i diabeti no komo in smrt.
In general, when patients are transferred from injection to infusion therapy, it may be advisable to reduce the dosage by initiating the patient at 90% of the previous total daily dosage, with 40% as basal rate and 50% as boluses divided between the three main meals. 
Na splošno utegne biti pri bolnikih, ki prehajajo z injekcijskega zdravljenja na zdravljenje z infuzijo, priporo ljivo zmanjšati odmerek, tako da bolnik za ne z 90 % prejšnjega celotnega dnevnega odmerka, in sicer s 40 % kot bazalna infuzija in 50 % kot bolusi, razdeljenimi med tri glavne obroke.
- If you have any further questions, ask your doctor, diabetes nurse or your pharmacist. 
- e imate dodatna vprašanja, se posvetujte z zdravnikom, diabetološko sestro ali farmacevtom.
Pharmacotherapeutic group: insulins and analogues for injection, fast-acting, insulin (human). 
Farmakoterapevtska skupina: insulini in analogi za injiciranje, s hitrim delovanjem, humani insulin.
To get the benefit of insulin infusion, and to detect possible malfunction of the pump, the patient should measure his blood glucose level regularly. 
Da bi infuzija insulina koristila in da bi odkril morebitno nepravilno delovanje rpalke, mora bolnik redno meriti koncentracijo glukoze v krvi.
The following substances may reduce insulin requirement: 
Potrebo po insulinu lahko zmanjšajo naslednje snovi:
A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin. 
Maloštevilni bolniki, ki so po prehodu z insulina živalskega izvora doživeli hipoglikemije, so navedli, da so bili zgodnji opozorilni simptomi hipoglikemije manj izraziti ali so se razlikovali od tistih, ki so jih doživeli s prejšnjim insulinom.
When you first start your treatment, it may disturb your vision, but the reaction usually disappears. 
Ko za nete prvi uporabljati zdravilo, lahko povzro i motnje vida, ki pa ponavadi izginejo.
When Velosulin is administered as a bolus injection onset of action is within ½ hour, reaches a maximum effect within 1.5-3.5 hours and the entire duration of action is approximately 7-8 hours. 
e je Velosulin uporabljen v bolusni injekciji, za ne delovati v ½ ure, doseže najve ji u inek v 1,53,5 urah in ima celotni as delovanja približno 7-8 ur.
Use only syringes made of polyethylene, polypropylene or glass. 
Uporabljajte samo brizge iz polietilena, polipropilena ali stekla.
Continuous rotation of the injection site within a given area may help to reduce or prevent these reactions. 
Stalno krožno menjavanje mest injiciranja na posameznem predelu pomaga zmanjšati ali prepre iti te reakcije.
Painful neuropathy (nerve related pain). 
Bole a nevropatija (z živci povezana bole ina).
You may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how to use it. 
Iz nezavesti se boste morda zbudili prej, e dobite injekcijo hormona glukagona; dati jo mora oseba, ki ga zna uporabljati.
Using glucagon 
Uporaba glukagona
Talk to your doctor or pharmacist if you take or have recently taken any other medicines, even those not prescribed. 
Posvetujte se z zdravnikom, e jemljete ali ste jemali katero koli drugo zdravilo, tudi e ste ga dobili brez recepta.
Your blood sugar may get too high (this is called hyperglycaemia). 
Sladkor v krvi se vam lahko preve zviša (to imenujemo hiperglikemija).
QUALITATIVE AND QUANTITATIVE COMPOSITION Insulin human, rDNA (produced by recombinant DNA technology in Saccharomyces cerevisiae). 
Humani insulin, rDNA (pridobljen s tehnologijo rekombinantne DNA iz Saccharomyces cerevisiae).
Velosulin should not be disposed of via wastewater or household waste. 
Zdravila Velosulin ne smete odvre i v odpadne vode ali med gospodinjske odpadke.
The daily insulin requirement may be higher in patients with insulin resistance (e.g. during puberty or due to obesity) and lower in patients with residual, endogenous insulin production. 
Dnevna potreba po insulinu je lahko ve ja pri bolnikih z odpornostjo proti insulinu (npr. med puberteto pri mladih ali zaradi debelosti) in manjša pri bolnikih z rezidualnim endogenim nastajanjem insulina.
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON Medicinal product subject to medical prescription 
• POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE, PREDPISANI IMETNIKU
Use only teflon-coated or stainless steel needles. 
Uporabljajte le s teflonom prekrite igle ali igle iz nerjave ega jekla.
An injection or infusion should be followed within 30 minutes by a meal or snack containing carbohydrates. 
Injekciji ali infuziji insulina mora po 30 minutah slediti obrok ali prigrizek, ki vsebuje ogljikove hidrate.
INFORMATION IN BRAILLE Velosulin 
PODATKI V BRAILLOVI PISAVI Velosulin
This leaflet is a general guide. 
To navodilo za uporabo obsega splošna navodila.
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. 
V primeru hipoglikemije je treba infuzijo ustaviti, dokler hipoglikemija ne mine.
The relatively fast absorption of soluble insulin ensures a constant supply of insulin to the blood from a relatively small pool under the skin. 
Razmeroma hitra absorpcija topnega insulina zagotavlja stalen dotok insulina v kri iz razmeroma majhne koli ine pod kožo.
After delivery, insulin requirements return rapidly to pre-pregnancy values. 
Po porodu se potreba po insulinu hitro vrne na vrednosti pred nose nostjo.
Your insulin will work more quickly if you inject it around the waist. 
Insulin bo deloval hitreje, e ga injicirate v predelu trebuha.
See the advice in 4 What to do in an emergency. 
Glejte nasvet v poglavju 4.
Velosulin is for injection under the skin (subcutaneously). 
Velosulin je namenjen injiciranju pod kožo (subkutani uporabi).
These symptoms are usually of transitory nature. 
Ponavadi so prehodne.
Causes of hyperglycaemia 
Vzroki za hiperglikemijo
Diabetic retinopathy (eye background changes). 
Diabeti na retinopatija (spremembe na o esnem ozadju).
If your blood sugar gets too high 
e se vam sladkor v krvi preve zviša
1 vial contains 10 ml equivalent to 1000 IU. 
1 viala vsebuje 10 ml, kar ustreza 1000 i.e.
Administration For subcutaneous or intravenous use. 
Za subkutano ali intravensko uporabo.
Read and follow carefully the instructions that accompany your insulin pump. 
Preberite in natan no upoštevajte navodila, priložena vaši insulinski rpalki.
Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4 ). 
Pri prehodu bolnikov z enega insulinskega pripravka na drugega utegne biti potrebna prilagoditev odmerjanja (glejte poglavje 4.4).
Velosulin may cause hypoglycaemia (low blood sugar). 
Velosulin lahko povzro i hipoglikemijo (nizek krvni sladkor).
On rare occasions, injection site reactions may require discontinuation of Velosulin. 
V redkih primerih utegne biti zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe zdravila Velosulin.
Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement. 
Spremljajo e bolezni, posebno okužbe in stanja z zvišano telesno temperaturo, ponavadi zve ajo bolnikovo potrebo po insulinu.
A specific overdose of insulin cannot be defined. 
Specifi nega prevelikega odmerjanja insulina ni mogo e definirati.
If it isn't in perfect condition when you get the vial, return the vial to your supplier If it hasn't been stored correctly or been frozen (see 6 How to store Velosulin) If it does not appear water clear and colourless. 
e ta tedaj, ko dobite vialo, ni v povsem brezhibnem stanju, vialo vrnite e ni bilo shranjeno pravilno ali je zmrznilo (glejte poglavje 6.
It is recommended that you measure your blood glucose regularly. 
Priporo ljivo je, da si redno merite glukozo v krvi.
The vial may be kept at room temperature (not above 25°C) for 6 weeks after first opening. 
Vialo lahko shranjujete pri sobni temperaturi (do 25 °C) 6 tednov po prvem odprtju.
If you have diabetic retinopathy and your blood glucose levels improve very fast, the retinopathy may get worse. 
e imate diabeti no retinopatijo in se vam koncentracija sladkorja v krvi zelo hitro izboljša, se retinopatija lahko poslabša.
This is a multipack and not for sale of individual vials 
To je pakiranje z ve vialami in ni namenjeno za prodajo posameznih vial.
Fast improvement in blood glucose control may be associated with a condition termed “acute painful neuropathy”, which is usually reversible. 
Hitro izboljšanje urejenosti glukoze v krvi lahko spremlja motnja, imenovana ˝akutna bole a nevropatija˝, ki je ponavadi reverzibilna.
Use in infusion pump 
Uporaba v infuzijski rpalki
Dosage is individual and determined in accordance with the needs of the patient. 
Odmerjanje je individualno in dolo eno skladno z bolnikovimi potrebami.
Reactions (redness, swelling, itching) at the injection site may occur (local allergic reactions). 
Pojavijo se lahko reakcije (pordelost, oteklina, srbenje) na mestu injiciranja (lokalne alergijske reakcije).
Clear, colourless, aqueous solution. 
Bistra, brezbarvna, vodna raztopina.
The terminal half-life (t½) is therefore a measure of the absorption rather than of the elimination per se of insulin from plasma (insulin in the blood stream has a t½ of a few minutes). 
Terminalni razpolovni as (t1/2) je torej merilo absorpcije, ne izlo anja insulina iz plazme per se (insulin v krvnem obtoku ima t1/2 nekaj minut).
Injection sites should be rotated within an anatomic region in order to avoid lipodystrophy. 
Mesta injiciranja je treba znotraj anatomskega predela krožno menjavati, da bi se izognili lipodistrofiji.
As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect. 
Tako kot pri drugih insulinih je praviloma najpogostejši neželeni u inek hipoglikemija.